During the past decade, Toledo Clinic - Oregon conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 59 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toledo Clinic - Oregon" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 64 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Eastern Cooperative Oncology Group" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "Radiation Therapy Oncology Group" with 5 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toledo Clinic - Oregon" #1 collaborator was "National Cancer Institute (NCI)" with 96 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Toledo Clinic - Oregon" are "Breast Cancer" (32 trials), "Lung Cancer" (15 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (7 trials) and "Metastatic Cancer" (6 trials). Many other conditions were trialed in "Toledo Clinic - Oregon" in a lesser frequency.

Most popular intervention types in "Toledo Clinic - Oregon" are "Drug" (77 trials), "Other" (40 trials), "Biological" (31 trials), "Radiation" (12 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (29 trials), "bevacizumab" (9 trials), "carboplatin" (8 trials), "cetuximab" (8 trials) and "radiation therapy" (8 trials). Other intervention names were less common.

The vast majority of trials in "Toledo Clinic - Oregon" are 73 trials for "All" genders, 21 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Toledo Clinic - Oregon". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 85 completed trials in Toledo Clinic - Oregon, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Toledo Clinic - Oregon, 4 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".